TY - CHAP M1 - Book, Section TI - Implementation Science A1 - Melvin, Cathy L. A1 - Brady, Kathleen T. A2 - Greenberg, Raymond S. PY - 2014 T2 - Medical Epidemiology: Population Health and Effective Health Care, 5e AB - Approximately 80% of individuals will become infected with human papillomavirus (HPV) during their lifetimes. Infection occurs at various sites in both sexes and may result in anogenital and oropharyngeal condyloma, precancers, or cancers. HPV causes more than 750,000 cases of cancer and 275,128 deaths worldwide per year. Comprehensive cancer screening, diagnosis, and treatment programs have reduced the incidence of HPV-related cancers where implemented, but these secondary cancer prevention efforts are associated with tremendous expense ($8 billion/year in the United States), complicated logistics, and significant morbidity. HPV vaccine offers an amazing opportunity to prevent the adverse outcomes associated with HPV infection. HPV vaccine is a safe, evidence-based intervention to prevent certain cancers and reduce health care costs. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1108591128 ER -